Cargando…
Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
Autor principal: | Leow, Melvin Khee Shing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338146/ https://www.ncbi.nlm.nih.gov/pubmed/32631373 http://dx.doi.org/10.1186/s13054-020-03097-w |
Ejemplares similares
-
Morbidity and Mortality Risks of Premature Enteral Nutrition During the Recovery of Myxedema Coma (A Response to the Article Entitled “Pediatric Patient With Altered Mental Status and Hypoxemia”)
por: Leow, Melvin Khee-Shing
Publicado: (2016) -
Glycated Hemoglobin (HbA1c): Clinical Applications of a Mathematical Concept
por: Leow, Melvin Khee Shing
Publicado: (2016) -
Characterization of the Asian Phenotype - An Emerging Paradigm with Clinicopathological and Human Research Implications
por: Leow, Melvin Khee-Shing
Publicado: (2017) -
A Review of the Phenomenon of Hysteresis in the Hypothalamus–Pituitary–Thyroid Axis
por: Leow, Melvin Khee-Shing
Publicado: (2016) -
Smoking, ACE-2 and COVID-19: ongoing controversies
por: Leung, Janice M., et al.
Publicado: (2020)